Red Blood Cell Transfusions clinical trials

Explore recruiting red blood cell transfusions clinical trials.

Recruiting red blood cell transfusions studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Red Blood Cell Transfusions trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Darbepoetin in patients candidates for liver transplant: randomized clinical trial (EPO_LT trial)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Double-Blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects with Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

Germany, Czechia, Romania, Ireland, Austria, Greece +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open label, multicenter roll-over extension program (REP) to characterize the long-term safety and tolerability of iptacopan (LNP023) in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who have completed PNH Phase 2 and Phase 3 studies with iptacopan.

Germany, Italy, Czechia, France, Spain, Netherlands +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

ErythroSIM : Randomized prospective trial evaluating the efficacy of the antiCD38 monoclonal antibody isatuximab in the treatment of PCRA by major ABO mismatch after allogeneic hematopoietic stem cell transplantation

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2 Study of REGN7257 (Anti-Interleukin 2 Receptor Subunit Gamma [IL2RG] Monoclonal Antibody) in Patients with Severe Aplastic Anemia that is Refractory to or Relapsed on Immunosuppressive Therapy

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

France, Belgium, Germany, Italy, Bulgaria, Ireland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Red Blood Cell Transfusions trials by city

Red Blood Cell Transfusions in Toronto Red Blood Cell Transfusions in Vancouver Red Blood Cell Transfusions in Montreal Red Blood Cell Transfusions in Calgary Red Blood Cell Transfusions in Edmonton Red Blood Cell Transfusions in Ottawa Red Blood Cell Transfusions in Winnipeg Red Blood Cell Transfusions in Quebec City Red Blood Cell Transfusions in Hamilton Red Blood Cell Transfusions in Kitchener Red Blood Cell Transfusions in London Red Blood Cell Transfusions in Halifax Red Blood Cell Transfusions in New York Red Blood Cell Transfusions in Los Angeles Red Blood Cell Transfusions in Chicago Red Blood Cell Transfusions in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease